How Many People Work at AbbVie? Headcount and Employee Trends

AbbVie is a research-driven biopharmaceutical company with roughly 26,700 employees worldwide. Recent data show the organization added about 1,750 new team members while 1,080 employees departed, pointing to steady, moderate growth. A wide range of scientific, commercial, and corporate roles supports the company’s portfolio of immunology, oncology, neuroscience, and eye-care therapies. This balanced hiring and attrition profile underscores AbbVie’s ongoing investment in innovation and global market presence.

Engineering is AbbVie’s largest single function with about 5,200 employees, representing nearly one-fifth of total headcount and highlighting the importance of process development and manufacturing science. Sales & Support follows closely at 4,800 employees (18%), enabling product reach across diverse therapeutic areas. Business Management, Healthcare, and Marketing & Product collectively account for roughly one-third of the workforce, indicating an emphasis on clinical expertise and go-to-market execution. Operations, Finance & Administration, Human Resources, and IT round out the organization, each reflecting between 3% and 8% of total staff, which provides a well-distributed backbone for global scale.

AbbVie maintains a broad geographic footprint. Approximately 5,900 employees are based in the Chicago metropolitan area, the largest single hub and home to key corporate and R&D facilities. Additional U.S. clusters include Boston, San Francisco, Irvine, Worcester, Los Angeles, Austin, and New York, each ranging from about 170 to 630 employees and supporting region-specific research, manufacturing, and commercial operations. An Irish presence of more than 300 employees anchors European manufacturing and supply functions. Two-thirds of AbbVie’s workforce is distributed across other global sites, reflecting the company’s diversified approach to serving patients and markets worldwide.